Foundation Medicine Company Profile (NASDAQ:FMI)

About Foundation Medicine

Foundation Medicine logoFoundation Medicine, Inc. is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. The Company's segment is the business of delivering molecular information about cancer to its customers. Its products provide genomic information about each patient's individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. Its flagship clinical molecular information products, FoundationOne for solid tumors, and FoundationOne Heme for blood-based cancers or hematologic malignancies, including leukemia, lymphoma, myeloma and advanced sarcomas, are genomic profiles designed for use in the routine care of patients with cancer. Its other products include FoundationACT (Assay for Circulating Tumor deoxyribonucleic acid (DNA)), GeneKit, FoundationCORE, FoundationICE and the SmartTrials program.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FMI
  • CUSIP:
Key Metrics:
  • Previous Close: $23.25
  • 50 Day Moving Average: $20.69
  • 200 Day Moving Average: $21.67
  • 52-Week Range: $14.25 - $27.55
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.61
  • P/E Growth: 0.00
  • Market Cap: $815.10M
  • Outstanding Shares: 35,058,000
  • Beta: -0.2
  • Net Margins: -84.67%
  • Return on Equity: -42.21%
  • Return on Assets: -35.70%
  • Current Ratio: 5.04%
  • Quick Ratio: 4.74%
Additional Links:
Companies Related to Foundation Medicine:

Analyst Ratings

Consensus Ratings for Foundation Medicine (NASDAQ:FMI) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings
Consensus Rating:Hold (Score: 1.83)
Consensus Price Target: $17.50 (24.73% downside)

Analysts' Ratings History for Foundation Medicine (NASDAQ:FMI)
DateFirmActionRatingPrice TargetDetails
11/3/2016Benchmark Co.DowngradeBuy -> HoldView Rating Details
8/4/2016BTIG ResearchReiterated RatingHoldView Rating Details
8/3/2016J P Morgan Chase & CoReiterated RatingHold$25.00View Rating Details
8/3/2016Janney Montgomery ScottDowngradeNeutral -> Sell$15.00View Rating Details
5/4/2016Leerink SwannReiterated RatingHoldView Rating Details
2/26/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$17.00 -> $15.00View Rating Details
11/4/2015WedbushLower Price TargetNeutral$26.00 -> $19.00View Rating Details
9/16/2015Wells Fargo & CompanyDowngradeOutperform -> Market PerformView Rating Details
7/30/2015JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/24/2015 forward)


Earnings History for Foundation Medicine (NASDAQ:FMI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2017Q416($0.96)($1.02)$29.23 million$28.80 millionViewListenView Earnings Details
11/2/2016Q316($0.88)($0.90)$28.70 million$29.43 millionViewN/AView Earnings Details
8/2/2016Q216($0.79)($0.84)$26.72 million$28.24 millionViewN/AView Earnings Details
5/3/2016Q116($0.72)($0.50)$25.20 million$30.40 millionViewN/AView Earnings Details
2/23/2016Q415($0.67)($0.55)$25.76 million$26.10 millionViewListenView Earnings Details
11/3/2015Q315($0.56)($0.60)$24.04 million$25.40 millionViewListenView Earnings Details
7/29/2015Q215($0.56)($0.98)$24.44 million$22.50 millionViewListenView Earnings Details
5/11/2015Q115($0.53)($0.59)$21.00 million$19.30 millionViewListenView Earnings Details
2/24/2015Q314($0.51)($0.47)$18.05 million$18.70 millionViewListenView Earnings Details
11/5/2014Q3($0.48)($0.46)$15.60 million$16.40 millionViewN/AView Earnings Details
8/12/2014Q214($0.48)($0.49)$13.39 million$14.50 millionViewN/AView Earnings Details
5/7/2014Q114($0.48)($0.44)$11.33 million$11.45 millionViewN/AView Earnings Details
2/25/2014Q413($0.43)($0.48)$9.01 million$9.66 millionViewN/AView Earnings Details
11/6/2013($0.51)($3.51)$6.92 million$8.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Foundation Medicine (NASDAQ:FMI)
Current Year EPS Consensus Estimate: $-3.20 EPS
Next Year EPS Consensus Estimate: $-2.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.60)($0.58)($0.59)
Q2 20162($0.58)($0.58)($0.58)
Q3 20162($0.55)($0.54)($0.55)
Q4 20162($0.53)($0.48)($0.51)
(Data provided by Zacks Investment Research)


Dividend History for Foundation Medicine (NASDAQ:FMI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Foundation Medicine (NASDAQ:FMI)
Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 31.44%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/8/2017Steven J KafkaCOOSell10,415$23.24$242,044.60View SEC Filing  
1/13/2017Jason RyanCFOSell1,777$19.00$33,763.00View SEC Filing  
1/4/2017David DalyInsiderSell5,097$17.91$91,287.27View SEC Filing  
1/4/2017Jason RyanCFOSell4,665$17.74$82,757.10View SEC Filing  
1/4/2017Michael J. PelliniCEOSell14,637$17.67$258,635.79View SEC Filing  
1/4/2017Robert W. HessleinSVPSell4,682$17.74$83,058.68View SEC Filing  
1/4/2017Steven J. KafkaCOOSell8,390$17.72$148,670.80View SEC Filing  
12/1/2016David DalyInsiderSell564$19.95$11,251.80View SEC Filing  
11/22/2016Steven J KafkaCOOSell6,273$23.01$144,341.73View SEC Filing  
10/20/2016Jason RyanCFOSell506$22.45$11,359.70View SEC Filing  
10/20/2016Steven J KafkaCOOSell4,427$23.00$101,821.00View SEC Filing  
10/4/2016David DalyInsiderSell2,045$23.65$48,364.25View SEC Filing  
10/4/2016Michael J. PelliniCEOSell2,629$23.65$62,175.85View SEC Filing  
10/4/2016Robert W. HessleinSVPSell1,220$23.65$28,853.00View SEC Filing  
10/4/2016Steven J. KafkaCOOSell2,135$23.62$50,428.70View SEC Filing  
9/20/2016Steven J KafkaCOOSell9,469$23.70$224,415.30View SEC Filing  
8/19/2016Jason RyanCFOSell13,863$23.92$331,602.96View SEC Filing  
7/5/2016David DalyInsiderSell5,008$17.76$88,942.08View SEC Filing  
7/5/2016Jason RyanCFOSell4,687$17.63$82,631.81View SEC Filing  
7/5/2016Michael J. PelliniCEOSell10,160$17.63$179,120.80View SEC Filing  
7/5/2016Robert W. HessleinSVPSell4,705$17.62$82,902.10View SEC Filing  
7/5/2016Steven J. KafkaCOOSell6,495$17.67$114,766.65View SEC Filing  
6/3/2016David DalyInsiderSell472$21.66$10,223.52View SEC Filing  
4/1/2016Steven J KafkaCOOSell124$18.08$2,241.92View SEC Filing  
4/1/2016Vincent A MillerInsiderSell356$18.08$6,436.48View SEC Filing  
12/1/2015David DalyInsiderSell2,559$16.78$42,940.02View SEC Filing  
11/13/2015Michael J PelliniCEOBuy9,100$16.43$149,513.00View SEC Filing  
6/15/2015Krishna YeshwantDirectorSell183,860$32.98$6,063,702.80View SEC Filing  
4/7/2015Alexis BorisyDirectorSell234,542$50.00$11,727,100.00View SEC Filing  
4/7/2015Roche Holdings IncInsiderBuy15,604,288$50.00$780,214,400.00View SEC Filing  
4/7/2015Rock Ventures Lp ThirdMajor ShareholderSell3,976,278$50.00$198,813,900.00View SEC Filing  
3/5/2015Michael J PelliniCEOSell153,300$47.24$7,241,892.00View SEC Filing  
1/15/2015Steven J KafkaCOOSell15,000$48.38$725,700.00View SEC Filing  
1/12/2015Michael J PelliniCEOSell22,500$51.07$1,149,075.00View SEC Filing  
1/12/2015Robert W HessleinSVPSell7,000$52.11$364,770.00View SEC Filing  
1/12/2015Steven J KafkaCOOSell8,000$51.83$414,640.00View SEC Filing  
1/12/2015Vincent A MillerInsiderSell2,000$53.03$106,060.00View SEC Filing  
1/8/2015Robert W HessleinSVPSell4,000$23.03$92,120.00View SEC Filing  
12/29/2014Michael J PelliniCEOSell12,500$23.91$298,875.00View SEC Filing  
11/17/2014Jason RyanSVPSell3,541$24.90$88,170.90View SEC Filing  
11/14/2014Michael J PelliniCEOSell12,500$24.91$311,375.00View SEC Filing  
10/27/2014Jason RyanSVPSell2,360$25.00$59,000.00View SEC Filing  
10/27/2014Steven J KafkaCOOSell10,000$25.31$253,100.00View SEC Filing  
9/15/2014Jason RyanSVPSell2,361$21.92$51,753.12View SEC Filing  
8/18/2014Michael J PelliniCEOSell12,500$25.29$316,125.00View SEC Filing  
7/22/2014Steven J KafkaCOOSell10,000$27.14$271,400.00View SEC Filing  
7/15/2014Jason RyanSVPSell3,541$27.22$96,386.02View SEC Filing  
7/15/2014Vincent A MillerInsiderSell15,000$27.25$408,750.00View SEC Filing  
7/8/2014Robert W HessleinSVPSell4,000$27.22$108,880.00View SEC Filing  
7/2/2014Michael J PelliniCEOSell15,000$27.42$411,300.00View SEC Filing  
6/26/2014Jason RyanSVPSell1,180$25.00$29,500.00View SEC Filing  
6/26/2014Steven J KafkaCOOSell5,000$25.19$125,950.00View SEC Filing  
6/19/2014Steven J KafkaCOOSell5,000$24.46$122,300.00View SEC Filing  
6/16/2014Jason RyanSVPSell2,361$22.61$53,382.21View SEC Filing  
6/13/2014Krishna YeshwantDirectorSell1,300,000$22.40$29,120,000.00View SEC Filing  
6/5/2014Jason RyanSVPSell10,000$24.06$240,600.00View SEC Filing  
6/5/2014Steven J KafkaCOOSell4,500$24.19$108,855.00View SEC Filing  
5/6/2014Vincent MillerInsiderSell3,000$30.00$90,000.00View SEC Filing  
4/16/2014Jason RyanSVPSell3,541$26.36$93,340.76View SEC Filing  
4/16/2014Vincent MillerInsiderSell30,000$26.86$805,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Foundation Medicine (NASDAQ:FMI)
DateHeadline logoEdited Transcript of FMI earnings conference call or presentation 22-Feb-17 9:30pm GMT (NASDAQ:FMI) - February 23 at 5:15 PM logoBRIEF-Foundation Medicine Q4 loss per share $1.02 (NASDAQ:FMI) - February 22 at 10:32 PM logoFOUNDATION MEDICINE, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:FMI) - February 22 at 10:32 PM logoFoundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook (NASDAQ:FMI) - February 22 at 10:32 PM
News IconInvestor Watch on Shares of Foundation Medicine, Inc. (NASDAQ:FMI) - Baldwin Journal (NASDAQ:FMI) - February 22 at 5:31 PM
News IconStock Buzz on Foundation Medicine, Inc. (NASDAQ:FMI): Can They Meet the Earnings Target of $-1.02 - Winfield Review (NASDAQ:FMI) - February 22 at 5:31 PM
News IconFoundation Medicine Inc (FMI) Releases Earnings Results, Misses Expectations By $-0.07 EPS - Highland Mirror (NASDAQ:FMI) - February 22 at 5:31 PM logoFoundation Medicine reports 4Q loss (NASDAQ:FMI) - February 22 at 5:31 PM logoIs the Options Market Predicting a Spike in Foundation Medicine (FMI) Stock? - Nasdaq (NASDAQ:FMI) - February 16 at 5:12 PM logoIs the Options Market Predicting a Spike in Foundation Medicine (FMI) Stock? (NASDAQ:FMI) - February 16 at 5:12 PM
News IconABR Of Foundation Medicine, Inc. (NASDAQ:FMI) Stock At 3 - Stock Observer (NASDAQ:FMI) - February 14 at 4:08 AM logoFoundation Medicine (FMI) Spikes Following Tuesday (NASDAQ:FMI) - February 8 at 5:45 PM logoFoundation Medicine Announces Timing for Fourth Quarter and Year-End 2016 Financial Results and Conference Call (NASDAQ:FMI) - February 6 at 11:21 AM logoBRIEF-Discovery Group I LLC reports 5.2 pct stake in Foundation Medicine as of Jan 19 - SEC Filing (NASDAQ:FMI) - January 30 at 5:59 PM logo[$$] Third Rock Ventures Adds Partner Focused on HR (NASDAQ:FMI) - January 28 at 12:00 AM
News IconEarnings in Full Force, Analysts Take Aim at Foundation Medicine, Inc. (NASDAQ:FMI) - Wall Street Beacon (NASDAQ:FMI) - January 26 at 6:43 PM logoImplied Volatility Surging for Foundation Medicine (FMI) Stock Options - Nasdaq (NASDAQ:FMI) - January 23 at 5:35 PM logoImplied Volatility Surging for Foundation Medicine (FMI) Stock Options (NASDAQ:FMI) - January 23 at 10:54 AM
News IconFoundation Medicine Inc FMI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:FMI) - January 21 at 5:13 PM logoInsider Selling: Foundation Medicine, Inc. (FMI) CFO Sells 1,777 Shares of Stock (NASDAQ:FMI) - January 20 at 6:34 PM logoBaron Funds Comments on Foundation Medicine (NASDAQ:FMI) - January 20 at 6:34 PM
News IconStock ABR Foundation Medicine, Inc. (NASDAQ:FMI) At 3 | Stock ... - Stock Observer (NASDAQ:FMI) - January 17 at 7:14 AM
News IconDavid Fabrizio Suggests Advantages of Genomic Profiling for Payers (NASDAQ:FMI) - January 14 at 5:19 PM
News IconWill The Needle Move For Foundation Medicine, Inc. (NASDAQ:FMI) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:FMI) - January 13 at 3:43 AM
News IconNotable Price Action: Foundation Medicine Inc on Focus After Raising In Today's Session - Fair View Times (NASDAQ:FMI) - January 13 at 3:43 AM logoFoundation Medicine (FMI): Moving Average Crossover Alert - Nasdaq (NASDAQ:FMI) - January 13 at 3:43 AM logoFoundation Medicine (FMI): Moving Average Crossover Alert (NASDAQ:FMI) - January 12 at 5:40 PM logoFoundation Medicine Reports Preliminary 2016 Results (NASDAQ:FMI) - January 9 at 6:04 PM logoFOUNDATION MEDICINE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial (NASDAQ:FMI) - January 9 at 6:04 PM logoBRIEF-Foundation Medicine Inc says Pellini named chairman of company's board (NASDAQ:FMI) - January 6 at 5:46 PM logoFoundation Medicine (FMI) Says Troy Cox to Succeed Michael Pellini as CEO (NASDAQ:FMI) - January 6 at 5:46 PM
News IconGenentech Alum Named CEO Of Foundation Medicine, Inc. (NASDAQ:FMI) - January 6 at 5:46 PM logoFoundation Medicine Announces Executive Leadership Transition (NASDAQ:FMI) - January 6 at 5:46 PM logoCambridge's Foundation Medicine gets new CEO in leadership shuffle (NASDAQ:FMI) - January 6 at 5:46 PM logoFOUNDATION MEDICINE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh (NASDAQ:FMI) - January 6 at 5:46 PM
News IconStock ABR Of Foundation Medicine, Inc. (NASDAQ:FMI) At 3 - Stock Observer (NASDAQ:FMI) - January 3 at 7:30 PM logoFoundation Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:FMI) - January 3 at 12:11 PM
News IconProjected EPS Of Foundation Medicine, Inc. (NASDAQ:FMI) At $-1 - Stock Observer (NASDAQ:FMI) - December 31 at 5:16 PM logoFoundation Medicine, Inc. (NASDAQ:FMI) Files An 8-K Other Events (NASDAQ:FMI) - December 21 at 6:06 PM logoFoundation Medicine (FMI) Announces FDA Approval of FoundationFocus, Companion Diagnostic for Rubraca - (NASDAQ:FMI) - December 21 at 2:17 AM logoFOUNDATION MEDICINE, INC. : Other Events (form 8-K) (NASDAQ:FMI) - December 20 at 8:44 PM logoFOUNDATION MEDICINE, INC. Files SEC form 8-K, Other Events (NASDAQ:FMI) - December 20 at 8:43 PM logoFoundation Medicine Inc. (FMI) Is Climbing After FDA Approval (NASDAQ:FMI) - December 20 at 10:21 AM logoETFs with exposure to Foundation Medicine, Inc. : December 19, 2016 (NASDAQ:FMI) - December 20 at 10:21 AM logo4:24 pm Foundation Medicine confirms FDA approval for FoundationFocus CDxBRCA for use as a companion diagnostic to aid in identifying women with ovarian cancer for whom treatment with Rubraca is being considered (NASDAQ:FMI) - December 20 at 10:21 AM logoFoundation Medicine Receives FDA Approval of FoundationFocus™ CDxBRCA as a Companion Diagnostic for Rubraca™ (rucaparib) for the Treatment of Women with Ovarian Cancer (NASDAQ:FMI) - December 20 at 10:21 AM
News IconFCF Score Check on Shares of Foundation Medicine, Inc. (NASDAQ:FMI) - Marion Business Daily (NASDAQ:FMI) - December 19 at 8:50 AM logoHere is What Hedge Funds Think About Foundation Medicine Inc (FMI) (NASDAQ:FMI) - December 18 at 5:19 PM
News IconFoundation Medicine, Inc. FMI Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:FMI) - December 17 at 5:29 PM logoETFs with exposure to Foundation Medicine, Inc. : December 8, 2016 (NASDAQ:FMI) - December 8 at 5:51 PM


What is Foundation Medicine's stock symbol?

Foundation Medicine trades on the NASDAQ under the ticker symbol "FMI."

Where is Foundation Medicine's stock going? Where will Foundation Medicine's stock price be in 2017?

6 equities research analysts have issued 12 month target prices for Foundation Medicine's stock. Their forecasts range from $15.00 to $25.00. On average, they expect Foundation Medicine's share price to reach $17.50 in the next twelve months.

When will Foundation Medicine announce their earnings?

Foundation Medicine is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

Who owns Foundation Medicine stock?

Foundation Medicine's stock is owned by a number of of institutional and retail investors. Top institutional investors include Discovery Group I LLC (4.55%), ARK Investment Management LLC (0.85%), State Street Corp (0.63%), Baillie Gifford & Co. (0.50%), FMR LLC (0.26%) and Russell Investments Group Ltd. (0.09%). Company insiders that own Foundation Medicine stock include Alexis Borisy, David Daly, Jason Ryan, Krishna Yeshwant, Michael J Pellini, Robert W Hesslein, Roche Holdings Inc, Rock Ventures Lp Third, Steven J Kafka and Vincent A Miller.

Who sold Foundation Medicine stock? Who is selling Foundation Medicine stock?

Foundation Medicine's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC. Company insiders that have sold Foundation Medicine stock in the last year include David Daly, Jason Ryan, Michael J Pellini, Robert W Hesslein, Steven J Kafka and Vincent A Miller.

Who bought Foundation Medicine stock? Who is buying Foundation Medicine stock?

Foundation Medicine's stock was acquired by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Discovery Group I LLC, Russell Investments Group Ltd., Moloney Securities Asset Management LLC, State Street Corp, GSA Capital Partners LLP, Metropolitan Life Insurance Co. NY and Commerzbank Aktiengesellschaft FI. Company insiders that have bought Foundation Medicine stock in the last two years include Michael J Pellini and Roche Holdings Inc.

How do I buy Foundation Medicine stock?

Shares of Foundation Medicine can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Foundation Medicine stock cost?

One share of Foundation Medicine stock can currently be purchased for approximately $23.25.

Foundation Medicine (NASDAQ:FMI) Chart for Friday, February, 24, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Foundation Medicine (NASDAQ:FMI)

Earnings History Chart

Earnings by Quarter for Foundation Medicine (NASDAQ:FMI)

Dividend History Chart

Dividend Payments by Quarter for Foundation Medicine (NASDAQ:FMI)

Last Updated on 2/24/2017 by Staff